Target class approach accelerates DUB inhibitory discovery

Special Seminar

Sara Buhrlage, PhD
Assistant Professor
Dana-Farber’s Cancer Biology Department
Harvard Medical School’s Biological Chemistry
& Molecular Pharmacology Department
Harvard Medical School